Search Results - james+johnson

2 Results Sort By:
Probiotics to treat or prevent gut colonization by drug-resistant E. Coli
Antibiotic-resistant bacteria threaten public health worldwide. One of the most widespread strains is Escherichia coli sequence type 131, which has a subclone lineage called H30R that is resistant to fluoroquinolones. This subtype, known as ST131-H30R, causes a large number of E. Coli infections that are resistant to antimicrobial treatment. The bacteria...
Published: 10/29/2024   |   Inventor(s): Cindy Liu, Daniel Park, Lance Price, James Johnson
Keywords(s):  
Category(s): Technology Classifications > Therapeutics
Mitochondrial-Targeted Peptide Modulators of Delta Protein Kinase C Interaction with the d-subunit of F1Fo ATP Synthase/ATPase as Therapeutics Against Cardiac Injury
Current State of the Art: Current clinical therapy for heart attack victims focuses on the rapid restoration of blood flow by thrombolysis, angioplasty, stenting and when appropriate surgical coronary artery bypass grafts. Problems with the Current Art: The majority of cardiac cell death associated with a heart attack actually occurs during the...
Published: 4/29/2020   |   Inventor(s): John Johnson, Tiffany Tuyen Nguyen, Mourad Ogbi
Keywords(s): Cardiovascular, Heart Attack, Therapeutics
Category(s): Therapeutics